At 40 weeks, participants taking 15 mg weekly of tirzepatide (the maximum dose of Mounjaro and Zepbound) lost 11.2% of their body weight
In 2025, there were 15.9 million outpatient encounters, 343,000 hospital admissions and observations, and 336,000 surgeries and procedures throughout Cleveland Clinics health system
Mass-compounded copies became illegal after the December 2024 shortage resolution
Mounjaro is primarily used for type 2 diabetes management, though it also supports significant weight loss in many patients
This exposes manufacturers to potentially heightened liability risks, particularly in the US, where a litigious culture increases the risk and financial impact of legal challenges
If you are interested in understanding how dosage calculations work across different weight loss compounds, the differences become even more apparent